Lavipharm SA operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Lavipharm SA with three other
pharmaceutical manufacturers in Europe:
Moberg Pharma AB (publ)
sales of 285.57 million Swedish Kronor [US$32.49 million]
of which 55%
was Nalox/Kerasal Nail, Sales of prodcuts),
Horizon Discovery Group PLC
of the United Kingdom
(£20.16 million [US$25.32 million]
of which 60%
was Services), and
Venture Life Group plc
based in the United Kingdom
(£9.08 million [US$11.40 million]
Lavipharm SA reported sales of 26.37 million Euro (US$28.66 million)
December of 2015.
decrease of 13.0%
versus 2014, when the company's sales were 30.30 million Euro.